Sponsor Pipeline

NextPoint Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06240728 A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2 Metastatic Malignant Neoplasm Recruiting
NCT07563829 NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies Metastatic Malignant Neoplasm Not Yet Recruiting
Get alerts when NextPoint Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free